Continuing Medical Education
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this educational activity for a maximum 1.50 of AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Who Should Attend
This educational activity is specifically designed for hematologists, internists, oncologists, and other physicians, physicians-in-training, and other healthcare professionals (nurse practitioners, physician assistants, nurses, pharmacists) interested and/or involved in the care of patients with lymphoma and myeloma.
Objectives
After successfully completing this continuing medical education activity, participants should be able to:
- Identify strategies that improve the recognition and management of patients with systemic amyloidosis
- Select the most appropriate pharmacotherapy regimen for patients with Waldenstrom’s macroglobulinemia
- Utilize emerging data to recommend induction therapies that achieve complete response and prolong survival in patients with multiple myeloma
Kenneth C. Anderson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
Raymond L. Comenzo, MD
Memorial Sloan-Kettering Cancer Center
New York, New York
Sundar Jagannath, MD
St. Vincent’s Comprehensive Cancer Center
New York, New York
Thursday, October 16, 2008
11:45 am
Introductions
11:50 am
Systemic amyloidosis:
Recognizing & managing a treacherous disease
Raymond L. Comenzo, MD
12:10 pm
Waldenstrom’s macroglobulinemia:
Who to treat, when to treat and how to treat
Sundar Jagannath, MD
12:30 pm Multiple myeloma: Complete response and prolonging survival through frontline therapeutic advances
Kenneth C. Anderson, MD
12:50 pm
Q & A
Attendees of this complimentary luncheon symposium must be registered for the Lymphoma & Myeloma 2008 An International congress on Hematologic Malignancies conference.
Waldorf=Astoria
Starlight Roof, 18th Floor
New York, New York
Course Chair
Kenneth C. Anderson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
ORGANIZER
Imedex
4325 Alexander Drive
Alpharetta, GA 30022-3740 USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2008 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
This educational activity is made possible by an unrestricted educational grant from:
Millennium Pharmaceuticals, Inc.
Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.
